Post-approval studies (Phase 4)Study completedNCT04377555
What this trial is testing
Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab
Who this might be right for
Multiple Sclerosis, Relapsing
Genentech, Inc. 179